
Sales of weight loss drug Wegovy more than doubled in the final three months of 2024, as manufacturer Novo Nordisk predicted growth will slow this year.
The Danish pharmaceutical company has become one of Europe’s largest companies on the back of soaring demand for its obesity treatments.